ADAMTS8

From WikiMD's WELLNESSPEDIA

(Redirected from Meth-2)

ADAMTS8 (A Disintegrin And Metalloproteinase with Thrombospondin Motifs 8) is a protein that in humans is encoded by the ADAMTS8 gene. This protein is part of the ADAMTS family, which is known for its role in various biological processes, including cell adhesion, proteolysis, and angiogenesis.

Function[edit]

ADAMTS8 is a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The enzyme encoded by this gene excises aggrecan and versican.

Clinical significance[edit]

ADAMTS8 has been implicated in a variety of diseases, particularly cancer. Reduced expression of this gene has been associated with various types of cancers, including lung cancer, breast cancer, and colorectal cancer. It is believed to act as a tumor suppressor by inhibiting angiogenesis.

Research[edit]

Research into ADAMTS8 is ongoing, with studies focusing on its role in cancer progression and potential as a therapeutic target. It is also being studied for its role in other diseases, such as rheumatoid arthritis and osteoarthritis.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.